PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 08/27/2019

Pipeline Type

New Formulations and Indications

Phase Of Development

Phase 1

Sponsors and Collaborators

Adamas Pharmaceuticals, Epilepsy Foundation (EF)

Mechanism of Action

Mechanism Description

Voltage Gated Sodium Channels (modified release of lacosamide)

Populations Tested In

Focal Seizures

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - Investment

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
AEDD XV - 2019

Location of Clinical Trials

N/A

Clinical Trial link

Join Our Newsletter

Want to get notified about new devices? Stay up to date with the latest epilepsy news and stories from the community.